MedTrace Logo

Implantology and Sjögren's Syndrome

NCT02661243 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2019-04-30

No results posted yet for this study

Summary

Until now it has not been investigated whether placement of implants in SS patients is less successful than compared to non-SS patients. The risk factors and the efficacy of dental implants in dry mouth patients are not known because of the lack of scientific evidence. The aim of this study is to investigate changes in marginal peri-implant bone loss and the clinical performance of dental implants in SS patients compared to implants in healthy patients.

Conditions

  • Sjogren's Syndrome

Interventions

DEVICE

Biohorizons Laser-lok bonelevel dental implants

Insertion of Biohorizons Laser-lok bonelevel dental implants to replace missing (pre)molars or to stabilize a denture

Sponsors & Collaborators

  • UMC Utrecht

    collaborator OTHER

  • University Medical Center Groningen

    collaborator OTHER

  • Tandartspraktijk Bocht Oosterdiep

    collaborator UNKNOWN

  • Isala

    collaborator OTHER

  • BioHorizons, Inc.

    collaborator INDUSTRY

  • Fonds NutsOhra

    collaborator OTHER

  • Derk Jan Jager

    lead OTHER

Principal Investigators

  • Derk Jan Jager, DMD, PhD · Amsterdam UMC, location VUmc

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2019-02-28
Completion
2019-02-28

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02661243 on ClinicalTrials.gov